tirzepatide type 2 diabetes Big update in pediatric care 🩺 Mounjaro® (tirzepatide) is now FDA-approved for children ≥10 years old with diabetes as an adjunct to diet and exercise. What this means ⬇️ Tirzepatide, a New Era of

powerfully shattering external pigment while systemically shutting down internal production

The following table provides a clinically useful framework

The released inflammatory mediators lead to the upregulation of adhesion molecules such as ICAM-1 on liver sinusoidal endothelial cells (LSECs) and hepatocytes as well as 2 integrins (CD11b/CD18) on neutrophils, which regulate the aggregation of immune cells through the production of mediators and the expression of adhesion molecules that assist neutrophil adhesion and transit within the sinusoids, adhesion to target cells and dependent oxidative stress, leading to hepatocyte death [19,20,21]

Lets break it down in a way that makes sensewithout the medical jargon